Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Successful treatment by on-demand glecaprevir and pibrentasvir for hepatitis C flare during R-CHOP in patients with diffuse large B-cell lymphoma: a case report

Fig. 1

Virologic response and clinical course of glecaprevir and pibrentasvir therapy for HCV and hepatitis flare during R-CHOP for DLBCL. Changes in the serum hepatitis C virus (HCV) titer, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) are shown. HCV, hepatitis C virus; ALT, alanine transaminase

Back to article page